Micron Q2 FY2026 Earnings — Peak Cycle Stress Test
Scenario Comparison
Q2 revenue >$19.5B (beats consensus $19.15B), Q3 FY2026 guided >$18.5B with GM >62%, management confirms shortage extends through CY2027+
HBM revenue exceeds $4B in Q2 (>21% of total), management provides HBM4 ramp details; addresses Samsung three-vendor competitive dynamics
Q2 revenue <$18.3B (misses guidance lower bound), margin miss, or management lowers FY2026 outlook
All Scenarios
7Positioning Suggestions
→ MU at $447 (~12x P/B): EXTREME CAUTION. Base case target $340 implies -24% downside. PW expected return approximately -25%. Even a beat may be sell-the-news given 4-quarter beat streak and Polymarket pricing 97.55% beat probability. Do NOT add. Consider trimming if Q3 guide disappoints.
→ AMAT: Read MU capex guidance closely. Tongluo acquisition + second facility could push total capex >$22B. If confirmed, validates AMAT's 'WFE super cycle' thesis. Lam (LRCX) has higher beta to memory capex.
→ LRCX: Highest beta play on MU capex. If capex guidance raised >$22B, Lam benefits most given ~50% DRAM etch share. But also highest risk if guidance is soft.
→ SNDK: Watch NAND commentary — MU's NAND guidance is the highest-signal data point for SNDK's recovery thesis. If NAND inventory normalized + ASPs rising → SNDK bull case strengthens.
→ SKHynix: Cross-reference MU's HBM share commentary with SKHynix's mid-50% allocation. Samsung HBM4 competition commentary affects both MU and SKHynix positioning.
→ Risk management: At $447 the asymmetry is severely negative. A beat is priced in. A miss or soft guide could trigger -10 to -15% move. Earnings are a binary event where the downside convexity far exceeds the upside at this price.
Predictions
15MU Q2 FY2026 revenue will exceed the $18.7B guidance midpoint
Expected — the real question is magnitude. Beat by >$500M validates cycle strength.
MU Q2 FY2026 revenue will exceed consensus $19.15B (beat the street, not just guidance)
If consensus beat → stock may rally despite elevated valuation. If miss consensus but beat guide → sell-the-news risk at $447.
MU Q2 FY2026 non-GAAP EPS will exceed consensus $8.69 per share
Beat history (14.4% avg surprise) strongly supports this. Key is whether beat magnitude approaches Most Accurate Estimate of $9.19.
Q3 FY2026 revenue guidance midpoint will be >$18.0B (extending the peak-cycle narrative)
If confirmed → bull confirmation; if guided <$17B → cycle peak thesis validated, consider trimming memory exposure
Q3 FY2026 gross margin guidance will be >60% (sustained peak margins through HBM mix)
If confirmed → HBM margin premium sustaining despite three-vendor competition; positive for SKHynix read-through
MU will report HBM revenue exceeding $3.5B in Q2 FY2026 (>19% of total revenue)
If confirmed → validates HBM structural demand thesis; positive for AMKR/ASE packaging volumes
Management will provide explicit Samsung HBM4 competitive commentary (acknowledging three-vendor market dynamics)
If Samsung pricing pressure mentioned → increase bear scenario probability; watch for defensive tone vs confident tone
FY2026 capex guidance will be revised upward from $20B to >$21B (reflecting Tongluo $1.8B acquisition)
If confirmed → strong positive for AMAT and LRCX (direct WFE demand); but raises MU operating leverage risk
Tongluo site will be specifically mentioned in prepared remarks with FY2028 production timeline details
Near-certain given 3/15 completion. Watch for any timeline acceleration to FY2027.
DRAM contract pricing commentary will indicate Q2 CY2026 QoQ increase decelerating to <30% (from 90-95% in Q1)
If deceleration steeper than expected → signals cycle peak; tighten stop-loss on memory positions
MU will report data center revenue mix exceeding 60% of total revenue (up from 56% in Q1 FY2026)
If confirmed → structural mix shift narrative strengthens; higher floor for trough margins vs prior cycles
MU stock will move more than 8% (either direction) on earnings day or the following session
MU stock will close BELOW $447 (current price) on earnings day despite beating guidance (sell-the-news)
At $447 with 97.55% Polymarket beat probability, a beat is priced in. Watch Q3 guide as the swing factor.
MU will announce NAND inventory normalization is complete with enterprise SSD ASPs rising
If confirmed → positive for SNDK (NAND recovery thesis validated)
At least one Wall Street analyst will downgrade MU within 48 hours of earnings (sell-the-news at peak valuation)
Key Questions
- Q3 FY2026 revenue and GM guidance — is the cycle extending or peaking? >$18B/62% = bull, <$17B/55% = bear
- HBM revenue quantum and trajectory — $3.5B? $4B+? Acceleration rate vs Q1 FY2026 ~$2B?
- HBM4 ramp status — yield, ASP premium vs HBM3E, and customer qualification timeline
- DRAM contract pricing guidance for Q2 CY2026 — magnitude of QoQ deceleration from 90-95%?
- Samsung HBM4 competitive commentary — acknowledging three-vendor market? Any pricing pressure?
- NAND pricing and inventory levels — has the NAND channel fully normalized?
- FY2026 capex update — impact of Tongluo $1.8B acquisition + second facility on total capex?
- Tongluo + Idaho fab production timeline — confirms FY2028 output or any acceleration?
- Data center revenue mix — above 60%? (was 56% in Q1 FY2026 after Crucial exit)
- Customer concentration — any commentary on NVIDIA dependency or diversification to AMD/hyperscalers?
- Any update on CXMT competitive threat in trailing-edge DRAM?